[
  {
    "ts": null,
    "headline": "Why West Pharmaceutical Services (WST) Stock Is Nosediving",
    "summary": "Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the company reported disappointing fourth-quarter 2024 results: its full-year revenue and earnings guidance fell short of Wall Street's estimates. Adjusted EPS declined slightly y/y, reflecting margin pressures and a less favorable product mix. These factors contributed to the lower-than-expected full-year EPS guidance.",
    "url": "https://finnhub.io/api/news?id=9df9c748cc74548f04ae91d076b8d6df79970caf22d8ee4e22800079e5704e0d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739472520,
      "headline": "Why West Pharmaceutical Services (WST) Stock Is Nosediving",
      "id": 132712625,
      "image": "https://s.yimg.com/ny/api/res/1.2/cSVWUL7WIq93L52E8CSKow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/stockstory_922/0a7131c3c60abde7f623f12aa0840d12",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the company reported disappointing fourth-quarter 2024 results: its full-year revenue and earnings guidance fell short of Wall Street's estimates. Adjusted EPS declined slightly y/y, reflecting margin pressures and a less favorable product mix. These factors contributed to the lower-than-expected full-year EPS guidance.",
      "url": "https://finnhub.io/api/news?id=9df9c748cc74548f04ae91d076b8d6df79970caf22d8ee4e22800079e5704e0d"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Stock Sinks On Weaker Than Expected 2025 Guidance",
    "summary": "On Thursday, West Pharmaceutical Services, Inc. (NYSE:WST) reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72. The designer and manufacturer of injectable pharmaceutical packaging and delivery systems reported sales of $748.8 million, beating the consensus of $740.47 million. The Proprietary Products Segment's sales increased by 3.4% to $613.9 million, and the organic net sales growth was 4.5%. High-value products (components and devices) represented around 74% of se",
    "url": "https://finnhub.io/api/news?id=a51a4943440458dd9cfa37898a97b35bd1946a3798480804d419c0ff693aedd6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739469115,
      "headline": "West Pharmaceutical Stock Sinks On Weaker Than Expected 2025 Guidance",
      "id": 132909984,
      "image": "https://media.zenfs.com/en/Benzinga/7f6f5c4f818bf368f54060fc5bf4d321",
      "related": "WST",
      "source": "Yahoo",
      "summary": "On Thursday, West Pharmaceutical Services, Inc. (NYSE:WST) reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72. The designer and manufacturer of injectable pharmaceutical packaging and delivery systems reported sales of $748.8 million, beating the consensus of $740.47 million. The Proprietary Products Segment's sales increased by 3.4% to $613.9 million, and the organic net sales growth was 4.5%. High-value products (components and devices) represented around 74% of se",
      "url": "https://finnhub.io/api/news?id=a51a4943440458dd9cfa37898a97b35bd1946a3798480804d419c0ff693aedd6"
    }
  },
  {
    "ts": null,
    "headline": "This Pharma Stock Is Today’s Worst in the S&P 500. Here’s Why.",
    "summary": "West Pharmaceutical Services  stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations.  Shares plunged 31% to $222.46, putting them on pace for their worst same-day percentage decrease in the company’s history.  The sharp downturn made West Pharmaceutical the worst-performing stock in the  on Thursday.",
    "url": "https://finnhub.io/api/news?id=b0c3de821c3b6449293773a9dd7c1adab7e26b8c62abc006116234d54293715f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739464140,
      "headline": "This Pharma Stock Is Today’s Worst in the S&P 500. Here’s Why.",
      "id": 132909986,
      "image": "https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services  stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations.  Shares plunged 31% to $222.46, putting them on pace for their worst same-day percentage decrease in the company’s history.  The sharp downturn made West Pharmaceutical the worst-performing stock in the  on Thursday.",
      "url": "https://finnhub.io/api/news?id=b0c3de821c3b6449293773a9dd7c1adab7e26b8c62abc006116234d54293715f"
    }
  },
  {
    "ts": null,
    "headline": "WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down",
    "summary": "West Pharmaceutical's overall top line in the fourth quarter of 2024 continues to benefit from revenue growth in its Proprietary Products segment.",
    "url": "https://finnhub.io/api/news?id=e7476ffbd676d5578d289bd1abd84db47425b786b4d744f76f6642db38bb6ee7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739462040,
      "headline": "WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down",
      "id": 132743933,
      "image": "https://media.zenfs.com/en/zacks.com/f4f040597ee01c61420a977a95c5b391",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical's overall top line in the fourth quarter of 2024 continues to benefit from revenue growth in its Proprietary Products segment.",
      "url": "https://finnhub.io/api/news?id=e7476ffbd676d5578d289bd1abd84db47425b786b4d744f76f6642db38bb6ee7"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. 2024 Q4 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by West Pharmaceutical Services, Inc.",
    "url": "https://finnhub.io/api/news?id=953734c4480eecedf83fa558460ba217e854e4c38f032bbf2953aaddedbd1a6a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739461902,
      "headline": "West Pharmaceutical Services, Inc. 2024 Q4 - Results - Earnings Call Presentation",
      "id": 132708710,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by West Pharmaceutical Services, Inc.",
      "url": "https://finnhub.io/api/news?id=953734c4480eecedf83fa558460ba217e854e4c38f032bbf2953aaddedbd1a6a"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings Call Transcript",
    "summary": "West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Conference Call February 13, 2025 9:00 AM ETCompany ParticipantsJohn Sweeney - Vice President...",
    "url": "https://finnhub.io/api/news?id=99d0035160ee70d59c4b3c3268060bee0c51b955b415b8bb6c681c8bffedece5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739461814,
      "headline": "West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings Call Transcript",
      "id": 132708680,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Conference Call February 13, 2025 9:00 AM ETCompany ParticipantsJohn Sweeney - Vice President...",
      "url": "https://finnhub.io/api/news?id=99d0035160ee70d59c4b3c3268060bee0c51b955b415b8bb6c681c8bffedece5"
    }
  },
  {
    "ts": null,
    "headline": "West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin",
    "summary": "West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin",
    "url": "https://finnhub.io/api/news?id=d090434d9145d8bc6c7b2485a72cfc0e56241a5d5fcca410e8087cbd08c506bb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739454540,
      "headline": "West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin",
      "id": 132720013,
      "image": "",
      "related": "WST",
      "source": "MarketWatch",
      "summary": "West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin",
      "url": "https://finnhub.io/api/news?id=d090434d9145d8bc6c7b2485a72cfc0e56241a5d5fcca410e8087cbd08c506bb"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates",
    "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of 4% and 1.25%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=9788978eb2aaab5d81f97255c12a93c256de5000b25f0ac2030540a0c6b8ead4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739448605,
      "headline": "West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates",
      "id": 132909990,
      "image": "https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of 4% and 1.25%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=9788978eb2aaab5d81f97255c12a93c256de5000b25f0ac2030540a0c6b8ead4"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical: Q4 Earnings Snapshot",
    "summary": "The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.75 per share. The medical device company posted revenue of $748.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $739.6 million.",
    "url": "https://finnhub.io/api/news?id=9d0dedb7c541c92300348edffadfdabc04f9ac297338fbd2307cc1ef51e7b58a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739445496,
      "headline": "West Pharmaceutical: Q4 Earnings Snapshot",
      "id": 132712626,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.75 per share. The medical device company posted revenue of $748.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $739.6 million.",
      "url": "https://finnhub.io/api/news?id=9d0dedb7c541c92300348edffadfdabc04f9ac297338fbd2307cc1ef51e7b58a"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services’s (NYSE:WST) Q4: Beats On Revenue But Stock Drops",
    "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue guidance of $2.89 billion at the midpoint came in 5% below analysts’ estimates. Its non-GAAP profit of $1.82 per share was 5.3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=cf7cf95de6abf6bfb091d95c9c3639e3f42b7036fd9620ffa9edb47d358dacc6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739444735,
      "headline": "West Pharmaceutical Services’s (NYSE:WST) Q4: Beats On Revenue But Stock Drops",
      "id": 132712627,
      "image": "https://s.yimg.com/ny/api/res/1.2/cSVWUL7WIq93L52E8CSKow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/stockstory_922/0a7131c3c60abde7f623f12aa0840d12",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue guidance of $2.89 billion at the midpoint came in 5% below analysts’ estimates. Its non-GAAP profit of $1.82 per share was 5.3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=cf7cf95de6abf6bfb091d95c9c3639e3f42b7036fd9620ffa9edb47d358dacc6"
    }
  },
  {
    "ts": null,
    "headline": "West Announces Fourth-Quarter and Full-Year 2024 Results",
    "summary": "West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024 and introduced 2025 financial guidance.",
    "url": "https://finnhub.io/api/news?id=5c7bc59fa16b08c00b4cdb639677702707cd8dbce02ac547dd82391bbec8d3e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739444400,
      "headline": "West Announces Fourth-Quarter and Full-Year 2024 Results",
      "id": 132909999,
      "image": "https://media.zenfs.com/en/prnewswire.com/383a8fcc44e20b256017f1f96ff3cc3f",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024 and introduced 2025 financial guidance.",
      "url": "https://finnhub.io/api/news?id=5c7bc59fa16b08c00b4cdb639677702707cd8dbce02ac547dd82391bbec8d3e1"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short",
    "summary": "West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short",
    "url": "https://finnhub.io/api/news?id=31ce78668be8657c3a632190957b84999df80038895980949308ab63336c53fc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739428500,
      "headline": "West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short",
      "id": 132732808,
      "image": "",
      "related": "WST",
      "source": "MarketWatch",
      "summary": "West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short",
      "url": "https://finnhub.io/api/news?id=31ce78668be8657c3a632190957b84999df80038895980949308ab63336c53fc"
    }
  }
]